DISEASE INDICATIONS: Breast Cancer, Gynaecological Cancer
MANUFACTURER: AstraZeneca AB
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Therapeutic Goods Administration (TGA)
Medsafe (NZ)
Lynparza, also known by its generic name Olaparib, represents a pivotal breakthrough in the field of oncology, specifically in the treatment of certain types of cancer, by harnessing the power of targeted therapy.
